Esophageal Cancer Research and Treatment
Esophageal Cancer Research and Treatment is a research topic within Surgery. Science Explorer counts 40k research works in it since 1950. 20.1% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the diagnosis, treatment, and management of esophageal cancer, with an emphasis on preoperative chemoradiotherapy, surgery, chemoradiation, and endoscopic resection. It also covers topics such as Barrett's esophagus, neoadjuvant therapy, adenocarcinoma, meta-analyses, and epidemiological trends.
- Preoperative Chemoradiotherapy
- Esophageal Carcinoma
- Barrett's Esophagus
- Surgery
- Chemoradiation
- Endoscopic Resection
- Neoadjuvant Therapy
- Adenocarcinoma
- Meta-analysis
- Epidemiology
- Research works
- 40k fractional, since 1950
- In the world top 10%
- 8k per year above
- Top-10% rate
- 20.1% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +33% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Esophageal Cancer Research and Treatment research?
By volume, China and the United States publish the most (2.5k and 1.4k works in 2022–2025).
By volume, 2022–2025
- 1 China 2.5k works
- 2 United States 1.4k works
- 3 Japan 1.1k works
- 4 United Kingdom 420 works
- 5 Germany 322 works
- 6 Netherlands 252 works
- 7 India 243 works
- 8 Italy 241 works
- 9 South Korea 227 works
- 10 Taiwan 144 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Esophageal Cancer Research and Treatment research?
By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Esophageal Cancer Research and Treatment research, followed by Sun Yat-sen University and Fujian Medical University.
By volume, 2022–2025
- 1 Chinese Academy of Medical Sciences & Peking Union Medical College China 81 works
- 2 Sun Yat-sen University China 63 works
- 3 Fujian Medical University China 60 works
- 4 Sichuan University China 55 works
- 5 National Cancer Center Hospital East Japan 47 works
- 6 West China Hospital of Sichuan University China 41 works
- 7 Nanjing Medical University China 40 works
- 8 The University of Texas MD Anderson Cancer Center United States 40 works
- 9 Memorial Sloan Kettering Cancer Center United States 38 works
- 10 First Affiliated Hospital of Zhengzhou University China 37 works
Who are the leading researchers in Esophageal Cancer Research and Treatment?
The most-cited researchers publishing on Esophageal Cancer Research and Treatment include Patrick M. Bossuyt, Gholamreza Roshandel and Farhad Islami.
- 1 Patrick M. Bossuyt 14k citations
- 2 Gholamreza Roshandel 5.4k citations
- 3 Farhad Islami 3.7k citations
- 4 Ying Liu 3.6k citations
- 5 Yi Zhang 3.6k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Esophageal Cancer Research and Treatment research done?
The largest centres of Esophageal Cancer Research and Treatment research in 2022–2025 are Beijing (China), Tokyo (Japan), Shanghai (China) and Guangzhou (China). Among places with at least 20 works in it, it is an unusually large share of all research in Kashiwa and Plainview.
Largest cities, 2022–2025
Where it is the local speciality
- KashiwaJP · 48.8 works65×
- PlainviewUS · 36.2 works57×
Location quotient: how much more of its research is in Esophageal Cancer Research and Treatment than the world average.
Where is the best place to study Esophageal Cancer Research and Treatment?
Among universities, judged by research, Chinese Academy of Medical Sciences & Peking Union Medical College, Hamamatsu University School of Medicine and Humanitas University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Chinese Academy of Medical Sciences & Peking Union Medical College China | 72.7 | 22.5% | 10.3× | 81 | +95.0% |
| 2 | Hamamatsu University School of Medicine Japan | 64.0 | 22.5% | 32.2× | 14 | +199.9% |
| 3 | Humanitas University Italy | 63.5 | 29.2% | 14.2× | 9 | +95.7% |
| 4 | Fujian Medical University China | 61.7 | 14.0% | 21.2× | 60 | +107.2% |
| 5 | Nanjing Medical University China | 59.9 | 20.3% | 9.8× | 40 | +34.2% |
| 6 | Shandong First Medical University China | 56.9 | 18.8% | 12.9× | 27 | +61.8% |
| 7 | Sun Yat-sen University China | 55.2 | 23.7% | 4.8× | 63 | +39.8% |
| 8 | Keio University Japan | 53.1 | 19.8% | 8.6× | 25 | +44.5% |
| 9 | Shanghai Medical College of Fudan University China | 52.6 | 25.7% | 14.5× | 9 | +14.1% |
| 10 | Xuzhou Medical College China | 51.9 | 17.7% | 9.0× | 15 | +124.5% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Esophageal Cancer Research and Treatment research growing?
Output in 2018–2022 was 33% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Esophageal Cancer Research and Treatment.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.